Literature DB >> 3728028

Branhamella catarrhalis: significance in pulmonary infections and bacteriological features.

J J Christensen, O Gadeberg, B Bruun.   

Abstract

A three-month survey revealed 29 patients at our hospital with symptoms of acute pulmonary infection, from whom Branhamella catarrhalis was isolated from lower respiratory tract specimens, in 18 cases in pure culture. Approximately 2% of all respiratory tract specimens examined during the period yielded growth of B. catarrhalis. All except one patient suffered from chronic pulmonary disease, notably chronic bronchitis. A phenotypic comparison was made between 55 strains of B. catarrhalis, of which 50 were recent isolates from lower respiratory tract specimens, and 23 Neisseria strains representing Neisseria meningitidis, Neisseria gonorrhoeae, Neisseria cinerea, Neisseria flavescens, Neisseria mucosa, Neisseria pharyngis, and Neisseria lactamica. The morphology of B. catarrhalis colonies is very characteristic, and when the diagnosis is suspected, testing for the ability to hydrolyze tributyrin may confirm it within hours. Ability to produce deoxyribonuclease is another property which differentiates B. catarrhalis from the Neisseria species. Otherwise, the combination of nitrate reduction and failure to produce acid from glucose, maltose, and sucrose establishes the diagnosis.

Entities:  

Mesh:

Year:  1986        PMID: 3728028     DOI: 10.1111/j.1699-0463.1986.tb03025.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  10 in total

1.  Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection.

Authors:  J J Christensen; N Q Hansen; B Bruun
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

2.  Branhamella catarrhalis in lower respiratory tract secretions in adults.

Authors:  H Schønheyder; T Ejlertsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

3.  Phenotypic characteristics of Branhamella catarrhalis strains.

Authors:  J L Soto-Hernandez; S Holtsclaw-Berk; L M Harvill; S L Berk
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 4.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

5.  Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection.

Authors:  J J Christensen; J Renneberg; B Bruun; A Forsgren
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

6.  Maternal antibodies and acquired serological response to Moraxella catarrhalis in children determined by an enzyme-linked immunosorbent assay.

Authors:  T Ejlertsen; E Thisted; P A Ostergaard; J Renneberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

7.  Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains.

Authors:  J S Fomsgaard; A Fomsgaard; N Høiby; B Bruun; C Galanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp.

Authors:  M Vaneechoutte; G Verschraegen; G Claeys; A M van den Abeele
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

9.  Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections.

Authors:  A J Black; T S Wilson
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

10.  Fastidious Gram-Negatives: Identification by the Vitek 2 Neisseria-Haemophilus Card and by Partial 16S rRNA Gene Sequencing Analysis.

Authors:  Ute Wolff Sönksen; Jens Jørgen Christensen; Lisbeth Nielsen; Annemarie Hesselbjerg; Dennis Schrøder Hansen; Brita Bruun
Journal:  Open Microbiol J       Date:  2010-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.